Frequency Therapeutics, Inc. (FREQ)
NASDAQ: FREQ · IEX Real-Time Price · USD
2.10
0.00 (0.00%)
Nov 29, 2022 3:48 PM EDT - Market open
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Revenue
|
14.07 | 36.98 | 28.95 | 0 | 0 |
| Revenue Growth (YoY)
|
-61.96% | 27.77% | - | - | - |
| Gross Profit
|
14.07 | 36.98 | 28.95 | 0 | 0 |
| Selling, General & Admin
|
37.18 | 27.12 | 14.84 | 7.06 | 4.34 |
| Research & Development
|
60.92 | 37.42 | 18.78 | 11.88 | 11.97 |
| Other Operating Expenses
|
0 | 0 | 16 | 0 | 0 |
| Operating Expenses
|
98.1 | 64.53 | 49.62 | 18.94 | 16.31 |
| Operating Income
|
-84.03 | -27.55 | -20.68 | -18.94 | -16.31 |
| Interest Expense / Income
|
0.37 | -0.99 | -1.78 | 0.11 | 0.17 |
| Other Expense / Income
|
0.27 | -0.08 | -0.15 | 0.12 | 3.76 |
| Pretax Income
|
-84.67 | -26.48 | -18.75 | -19.17 | -20.24 |
| Income Tax
|
0.02 | 0.04 | 0 | 0 | 0 |
| Net Income
|
-84.69 | -26.51 | -18.75 | -19.17 | -20.24 |
| Preferred Dividends
|
0 | 0 | 1.05 | 0 | 0 |
| Net Income Common
|
-84.69 | -26.51 | -19.8 | -19.17 | -20.24 |
| Shares Outstanding (Basic)
|
34 | 32 | 9 | 2 | 1 |
| Shares Outstanding (Diluted)
|
34 | 32 | 9 | 2 | 1 |
| Shares Change
|
6.50% | 272.90% | 465.23% | 117.69% | - |
| EPS (Basic)
|
-2.47 | -0.82 | -2.29 | -12.53 | -28.79 |
| EPS (Diluted)
|
-2.47 | -0.82 | -2.29 | -12.53 | -28.79 |
| Free Cash Flow Per Share
|
-2.30 | -1.61 | 3.83 | -11.41 | -23.44 |
| Gross Margin
|
100.00% | 100.00% | 100.00% | - | - |
| Operating Margin
|
-597.30% | -74.50% | -71.40% | - | - |
| Profit Margin
|
-602.00% | -71.70% | -68.40% | - | - |
| Free Cash Flow Margin
|
-561.40% | -140.20% | 114.50% | - | - |
| Effective Tax Rate
|
-0.02% | -0.13% | 0.00% | 0.00% | 0.00% |
| EBITDA
|
-80.46 | -25.89 | -19.72 | -18.41 | -19.53 |
| EBITDA Margin
|
-572.00% | -70.00% | -68.10% | - | - |
| Depreciation & Amortization
|
3.84 | 1.58 | 0.81 | 0.65 | 0.53 |
| EBIT
|
-84.3 | -27.47 | -20.53 | -19.06 | -20.06 |
| EBIT Margin
|
-599.30% | -74.30% | -70.90% | - | - |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).